Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in September 2026 (Volume 27, Issue 3) Submit Paper

Peripartum cardiomyopathy: Case report

Breadcrumb

  • Home
  • Peripartum cardiomyopathy: Case report

Lahari Samudrala 1, *, Meenakshi Addula 2, Jhansi Rani Gandamala 2, Rajeez Aliyangattuvageri 2 and Ramarao Tadikonda 3

1 Assistant Professor, Department of Pharm D, CMR College of pharmacy, Hyderabad, India.

2 Students, Department of Pharm D, CMR College of Pharmacy.

3 Principal, CMR College of Pharmacy, Hyderabad, India.

Case Report

World Journal of Biology Pharmacy and Health Sciences, 2025, 21(02), 232-235

Article DOI: 10.30574/wjbphs.2025.21.2.0117

DOI url: https://doi.org/10.30574/wjbphs.2025.21.2.0117

Received on 19 December 2024; revised on 04 February 2025; accepted on 07 February 2025

Systolic heart failure which develops in the last month of pregnancy or within five months following childbirth is an important hallmark of peripartum cardiomyopathy (PPCM), a type of dilated cardiomyopathy. Despite being identified in the 1800s, the exact cause of PPCM remains uncertain. The incidence of peripartum cardiomyopathy in India is estimated to be 1 in 453 to 1 in1340 live births. However, because its symptoms mimic those of a typical pregnancy and postpartum period, diagnosing it can be difficult due to its high mortality rate and PPCM can have serious consequences if it is misdiagnosed or delayed.

In our case report, we present a patient who developed shortness of breath since past 1 week associated with orthopnea after a spontaneous delivery. After careful evaluation, we identified the symptoms as heart failure resulting from peripartum cardiomyopathy. The treatment approach included symptomatic measures employing diuretics, ACE inhibitors and HMG Co A reductase inhibitors, Anti platelets. Fortunately, mechanical cardiac support was not necessary, and the signs of heart failure improved within three weeks. Furthermore, during the follow-up period of one year, the patient's left ventricular clot returned to normal, maintaining a positive state of health.

Peripartum; Cardiomyopathy; Heart Failure; Treatment

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2025-0117.pdf

Preview Article PDF

Lahari Samudrala, Meenakshi Addula, Jhansi Rani Gandamala, Rajeez Aliyangattuvageri and Ramarao Tadikonda. Peripartum cardiomyopathy: Case report. World Journal of Biology Pharmacy and Health Sciences, 2025, 21(02), 232-235. Article DOI: https://doi.org/10.30574/wjbphs.2025.21.2.0117.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution